Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 3.

Article

Brodsky, RA, Peffault de Latour, R, Rottinghaus, ST et al. (15 more authors) (2020) Characterization of breakthrough hemolysis events observed in the phase 3 randomized studies of ravulizumab versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria. Haematologica. ISSN 0390-6078

Hillmen, P orcid.org/0000-0001-5617-4403, Muus, P, Röth, A et al. (11 more authors) (2013) Long‐term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, 162 (1). pp. 62-73. ISSN 0007-1048

Proceedings Paper

Peffault De Latour, R, Mitchell, L, Brodsky, RA et al. (10 more authors) (2019) Ravulizumab (ALXN1210) versus eculizumab in adults with paroxysmal nocturnal hemoglobinuria: pharmacokinetics and pharmacodynamics observed in two Phase 3 randomized, multicenter studies. In: British Journal of Haematology. 59th Annual Scientific Meeting of the British Society for Hematology, 01-03 Apr 2019, Glasgow, UK. Wiley , p. 110.

This list was generated on Sun Jul 5 05:53:04 2020 BST.